Kiniksa Pharmaceuticals Ltd (NASDAQ:KNSA)

12.42
Delayed Data
As of Aug 12
 +0.26 / +2.14%
Today’s Change
7.36
Today|||52-Week Range
15.25
+5.52%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2016

2017

2018

--
Operating ActivitiesNet Income / Starting Line-24.0M-64.9M-103.2M--
 
 
 
 
Depreciation22.0K28.0K286.0K--
 
 
 
 
Total Other Cash Flow368.0K897.0K4.6M--
 
 
 
 
Funds From Operations-23.6M-64.1M-99.3M--
 
 
 
 
Funds From/For Other Operating Expenses-1.8M-13.9M-18.3M--
 
 
 
 
Net Cash Flow - Operating Activities-21.9M-50.2M-81.0M--
 
 
 
 
 
InvestingIncrease In Investments0.000.00-402.0M--
 
 
Decrease In Investments0.000.00168.1M--
 
 
Capital Expenditures-3.0K-69.0K-5.3M--
 
 
 
 
Net Cash Flow Investing-3.0K-69.0K-239.2M--
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.00----
Long Term Borrowings0.000.000.00----
Long Term Debt Reduction0.000.000.00----
Net Proceeds Stock Sale42.5M39.9M346.7M--
 
 
 
 
Common Preferred Redeemed0.000.000.00----
Common Dividends0.000.000.00----
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing0.000.000.00----
Other Uses - Financing0.000.000.00----
Net Cash Flow - Financing42.5M39.9M346.7M--
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash20.6M-10.4M26.5M--